[Prognostic value of stress echocardiography by dobutamine combined with atropine].
OBJECTIVE
To determine the prognostic value of dobutamine-atropine stress echocardiography (DASE).


METHODS
We studied 452 consecutive patients at high risk for coronary artery disease, using DASE. They were followed during a mean period of 23 months.


RESULTS
There were 9 cardiac deaths and 2 acute myocardial infarctions in the group of patients with positive tests, and there were 2 myocardial infarctions and 1 cardiac death in patients with negative DASE.


CONCLUSIONS
We conclude that DASE reliably identifies patients at high risk for hard cardiac events.
Mathias Júnior
W
W
Escola Paulista de Medicina-UNIFESP e Hospital Unicor, São Paulo.
Stella
U
U
Baruta
F
F
Cordovil
A
A
Andrade
J L
JL
Carvalho
A C
AC
Ribeiro
E
E
Duprat
R
R
Martinez
E
E
D000889:Anti-Arrhythmia Agents; D001285:Atropine; D002316:Cardiotonic Agents; D003327:Coronary Disease / Q000000981:diagnostic imaging*; D004280:Dobutamine; D004338:Drug Combinations; D005080:Exercise Test; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012307:Risk Factors; D014463:Ultrasonography
D000889:Anti-Arrhythmia Agents; D002316:Cardiotonic Agents; D004338:Drug Combinations; D004280:Dobutamine; D001285:Atropine